A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

NCT01637402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Castration Resistant Prostate Cancer

Interventions

DRUG: Abiraterone Acetate
DRUG: Prednisone

Sponsor

Terence Friedlander, MD

Collaborators

[object Object]